Want to see TSE:KNE full AI Analyst Report?
Kane Biotech (KNE) Financial Statements
2 Followers
Kane Biotech Financial Overview
Kane Biotech's market cap is currently C$7.18M. The company's EPS TTM is C$-0.01; its P/E ratio is -2.40; Kane Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 427.87K | C$ 2.08M | C$ 148.98K | C$ 156.73K | C$ 1.61M |
| Gross Profit | C$ -163.38K | C$ 872.10K | C$ 109.47K | C$ 1.41M | C$ 568.44K |
| Operating Income | C$ -3.11M | C$ -4.49M | C$ -3.36M | C$ -3.46M | C$ -4.88M |
| EBITDA | C$ -2.95M | C$ -3.71M | C$ -3.11M | C$ -2.95M | C$ -4.25M |
| Net Income | C$ -2.72M | C$ -3.02M | C$ -5.03M | C$ -3.89M | C$ -4.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 901.70K | C$ 358.81K | C$ 749.25K | C$ 1.10M | C$ 1.15M |
| Total Assets | C$ 2.73M | C$ 2.49M | C$ 5.68M | C$ 5.62M | C$ 6.13M |
| Total Debt | C$ 2.30M | C$ 2.29M | C$ 9.26M | C$ 6.86M | C$ 4.71M |
| Net Debt | C$ 1.40M | C$ 1.93M | C$ 8.51M | C$ 5.75M | C$ 3.56M |
| Total Liabilities | C$ 3.48M | C$ 4.12M | C$ 14.09M | C$ 9.76M | C$ 7.70M |
| Stockholders' Equity | C$ -746.54K | C$ -1.63M | C$ -10.56M | C$ -6.52M | C$ -3.89M |
| Cash Flow | |||||
| Free Cash Flow | C$ -3.26M | C$ -4.14M | C$ -3.23M | C$ -3.13M | C$ -2.64M |
| Operating Cash Flow | C$ -3.26M | C$ -4.11M | C$ -3.22M | C$ -3.04M | C$ -2.29M |
| Investing Cash Flow | C$ -53.13K | C$ 10.27M | C$ -116.14K | C$ -107.55K | C$ -373.55K |
| Financing Cash Flow | C$ 3.85M | C$ -7.69M | C$ 2.98M | C$ 3.10M | C$ 2.81M |
Currency in CAD
